The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients

Cancer Immunology, Immunotherapy

Volumn 55, Issue 10, 2006, Pages 1247-1257

  Skopeliti, Margarita ^a   Voutsas, Ioannis F ^a   Klimentzou, Persefoni ^b   Tsiatas, Marinos L ^a   Beck, Alexander ^c   Bamias, Aristotelis ^a   Moraki, Maria ^d   Livaniou, Evangelia ^b   Neagu, Monica ^e   Voelter, Wolfgang ^f   Tsitsilonis, Ourania E ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d SAINT SAVVAS HOSPITAL   (Greece)

^e VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^f UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anticancer activity; Cell proliferation; Cytotoxicity; Immune responses; Prothymosin fragmentation

Indexed keywords

CASPASE; CELL ADHESION MOLECULE; INTERLEUKIN 2 RECEPTOR ALPHA; PERFORIN; POLYPEPTIDE; PROTHYMOSIN ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER PATIENT; CARBOXY TERMINAL SEQUENCE; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; EVALUATION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 33745635719     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-005-0108-4     Document Type: Article

References (48)

1. 1 in rat thymus. Proc Natl Acad Sci USA 81:1008-1011
2. Haritos AA (1987) α-Thymosins: relationships in structure, distribution, and function. Isozymes Curr Top Biol Med Res 14:123-152
3. Eschenfeldt WH, Berger SL (1986) The human prothymosin α gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc Natl Acad Sci USA 83:9403-9407
4. Pineiro A, Cordero OJ, Nogueira M (2000) Fifteen years of prothymosin alpha: contradictory past and new horizons. Peptides 21:1433-1446
5. Tsitsiloni OE, Stiakakis J, Koutselinis A, Gogas J, Markopoulos C, Yialouris P, Bekris S, Panoussopoulos D, Kiortsis V, Voelter W, Haritos AA (1993) Expression of α-thymosins in human tissues in normal and abnormal growth. Proc Natl Acad Sci USA 90:9504-9507
6. Eilers M, Schirm S, Bishop JM (1991) The MYC protein activates transcription of the α-prothymosin gene. EMBO J 10:133-141
7. Perez-Estevez A, Diaz-Jullien C, Covelo G, Salgueiro MT, Freire M (1997) A 180-kDa protein kinase seems to be responsible for the phosphorylation of prothymosin α observed in proliferating cells. J Biol Chem 272:10506-10513
8. Manrow RE, Sburlati AR, Hanover JA, Berger SL (1991) Nuclear targeting of prothymosin α. J Biol Chem 266:3916-3924
9. Diaz-Jullien C, Perez-Estevez A, Covelo G, Freire M (1996) Prothymosin α binds histones in vitro and shows activity in nucleosome assembly assay. Biochim Biophys Acta 1296:219-227
10. Karetsou Z, Kretsovali A, Murphy C, Tsolas O, Papamarcaki T (2002) Prothymosin α interacts with the CREB-binding protein and potentiates transcription. EMBO Rep 3:361-366
11. Trumbore MW, Wang RH, Enkemann SA, Berger SL (1997) Prothymosin α in vivo contains phosphorylated glutamic acid residues. J Biol Chem 272:26394-26404
12. Cotter MA, Robertson ES (2000) Modulation of histone acetyltransferase activity through interaction of Epstein-Barr nuclear antigen 3C with prothymosin alpha. Mol Cell Biol 20:5722-5735
13. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, Burns D, Ng SC, Rosenberg S, Wang X (2003) Distinctive roles of PHAP proteins and prothymosin-α in a death regulatory pathway. Science 299:223-226
14. Segade F, Gomez-Marquez J (1999) Prothymosin α. Int J Biochem Cell Biol 31:1243-1248
15. Baxevanis CN, Frillingos S, Seferiadis K, Reclos GJ, Arsenis P, Katsiyiannis A, Anastasopoulos E, Tsolas O, Papamichail M (1990) Enhancement of human T lymphocyte function by prothymosin α: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes. Immunopharmacol Immunotoxicol 12:595-617
16. Garbin F, Eckert K, Immenschuh P, Kreuser ED, Maurer HR (1997) Prothymosin α1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients. Int J Immunopharmacol 19:323-332
17. Baxevanis CN, Thanos D, Reclos GJ, Anastasopoulos E, Tsokos GC, Papamatheakis J, Papamichail M (1992) Prothymosin α enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation. J Immunol 148:1979-1984
18. Voutsas IF, Baxevanis CN, Gritzapis AD, Missitzis I, Stathopoulos GP, Archodakis G, Banis C, Voelter W, Papamichail M (2000) Synergy between interleukin-2 and prothymosin α for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas. Cancer Immunol Immunother 49:449-458
19. Baxevanis CN, Gritzapis AD, Spanakos G, Tsitsilonis OE, Papamichail M (1995) Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α. Cancer Immunol Immunother 40:410-418
20. Heidecke H, Eckert K, Schulze-Forster K (1997) Prothymosin α1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients. Int J Immunopharmacol 19:413-420
21. Enkemann SA, Wang RH, Trumbore MW, Berger SL (2000) Functional discontinuities in prothymosin α caused by caspase cleavage in apoptotic cells. J Cell Physiol 182:256-268
22. Evstafieva AG, Belov GA, Kalkum M, Chichkova NV, Bogdanov AA, Agol VI, Vartapetian AB (2000) Prothymosin α fragmentation in apoptosis. FEBS Lett 467:150-154
23. Baxevanis CN, Spanakos G, Voutsas IF, Gritzapis AD, Tsitsilonis OE, Mamalaki A, Papamichail M (1999) Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α. Cancer Immunol Immunother 48:71-84
24. + T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor. J Immunol 164:3902-3912
25. Raziuddin S, Abu-Eshy S, Sheikka A (1994) Peripheral T-cell lymphomas. Immunoregulatory cytokine (interleukin-2, interleukin-4, and interferon-γ) abnormalities and autologous mixed lymphocyte reaction. Cancer 74:2843-2849
26. Goldstein AL, Badamchian M (2004) Thymosins: chemistry and biological properties in health and disease. Expert Opin Biol Ther 4:559-573
27. - subset from PBL and NK cells in long-term IL-2 cultures enhanced by prothymosin-α. Immunopharmacology 29:215-223
28. Eckert K, Gruenberg E, Immenschuh P, Gabrin F, Kreuser ED, Maurer HR (1997) Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin α1. J Cancer Res Clin Oncol 123:420-428
29. Eckert K, Schmitt M, Gabrin F, Wahn U, Maurer HR (1994) Thymosin α1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results. Int J Immunopharmacol 16:1019-1025
30. Garbin F, Eckert K, Buttner P, Garbe C, Maurer HR (1994) Prothymosin α augments deficient antitumor activity of monocytes from melanoma patients in vitro. Anticancer Res 14:2405-2411
31. Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41-49
32. Baxevanis CN, Reclos GJ, Panneerselvam C, Papamichail M (1988) Enhancement of human T lymphocyte functions by prothymosin α. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses. Immunopharmacology 15:73-84
33. Baxevanis CN, Reclos GJ, Papamichail M (1993) Prothymosin α restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer. Int J Cancer 53:264-268
34. Eschenfeldt WH, Manrow RE, Krug MS, Berger SL (1989) Isolation and partial sequencing of the human prothymosin α gene family. Evidence against export of the gene products. J Biol Chem 264:7546-7555
35. Evstafieva AG, Belov GA, Rubtsov YP, Kalkum M, Joseph B, Chichkova NV, Sukhacheva EA, Bogdanov AA, Pettersson RF, Agol VI, Vartapetian AB (2003) Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha. Exp Cell Res 284:211-223
36. Cordero OJ, Sarandeses C, Nogueira M (1994) Prothymosin α receptors on peripheral blood mononuclear cells. FEBS Lett 341:23-27
37. Cordero OJ, Sarandeses CS, Lopez JL, Cancio E, Regueiro BJ, Nogueira M (1991) Prothymosin α enhances interleukin 2 receptor expression in normal human T-lymphocytes. Int J Immunopharmacol 13:1059-1065
38. Lopez-Rodriguez JL, Cordero OJ, Sarandeses CS, Vinuela J, Nogueira M (1994) Interleukin-2 killer cells: in vitro evaluation of combination with prothymosin α. Lymphokine Cytokine Res 13:175-182
39. Crump WL, Owen-Schaub LB, Grimm EA (1989) Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells. Cancer Res 49:149-153
40. Gruenberg E, Eckert K, Maurer R (1997) Prothymosin α1 enhances the interleukin-2 activated killer cell adhesion to and immunotoxicity against docetaxel-treated HT-29 colon carcinoma cells in vitro. Int J Thymol 5:415-423
41. Pross HF, Lotzova E (1993) Role of natural killer cells in cancer. Nat Immun 12:279-292
42. Odman-Ghazi SO, Hatcher F, Whalen MM (2003) Expression of functionally relevant cell surface markers in dibutyltin-exposed human natural killer cells. Chem Biol Interact 146:1-18
43. Rose DM, Cardarelli PM, Cobb RR, Ginsberg MH (2000) Soluble VCAM-1 binding to α4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood 95:602-609
44. 11 by a lysosomal asparaginyl endopeptidase. J Biol Chem 278:13286-13293
45. Shiau AL, Lin PR, Chang MY, Wu CL (2001) Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer. Gene Ther 8:1609-1617
46. Shakulov VR, Vorobjev IA, Rubtsov YP, Chichkova NV, Vartapetian AB (2000) Interaction of yeast importin α with the NLS of prothymosin α is insufficient to trigger nuclear uptake of cargos. Biochem Biophys Res Commun 274:548-552
47. Romani L, Bistoni F, Gaziano R, Bozza S, Montagnoli C, Perruccio K, Pitzurra L, Bellocchio S, Velardi A, Rasi G, Di Francesco P, Garaci E (2004) Thymosin α1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 103:4232-4239
48. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-305